Patent · US Active

Humanized anti-CD4 antibody with immunosuppressive properties

US9758581B2 · kind B2 · utility

18Cited by

26References

15Claims

0Family size

Assignee

Biotest AG · DE

Inventors

John Wijdenes · Larnod, FR
Helmut Jonuleit · Ginsheim-Gustavsburg, DE

Key dates

Filing date	Feb 10, 2014
Grant date	Sep 12, 2017
Priority date	—
Expiry date	Nov 30, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/73
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A humanized antibody derived from mouse monoclonal anti-CD4 antibody B-F5 is able to activate CD25+CD4+ regulatory T cells and is useful for preparing immunosuppressive compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.